{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:42:17Z","timestamp":1773286937032,"version":"3.50.1"},"reference-count":31,"publisher":"American Society of Hematology","issue":"9","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fas-mediated apoptosis is a major physiologic mechanism by which activated T cells are eliminated after antigen-stimulated clonal expansion generates a specific cellular immune response. Because activated T cells are the major effectors of allograft rejection, we hypothesized that genetically modifying allogeneic bone marrow (BM) cells prior to transplantation could provide some protection from host T-cell attack, thus enhancing donor cell engraftment in bone marrow transplantation (BMT). We undertook studies to determine the outcome of lentiviral vector-mediated transduction of Fas ligand (FasL) into lineage antigen-negative (lin\u2212) mouse BM cells (lin\u2212 BMs), in an allogeneic BMT model. FasL-modified lin\u2212 BMs killed Fas-expressing T cells in vitro. Mice that received transplants of allogeneic FasL+ lin\u2212BMs had enhanced short-term engraftment, after nonmyeloablative conditioning, as compared to controls. We observed no major hepatic toxicity or hematopoietic or immune impairment in recipient mice at these time points. These results suggest potential therapeutic approaches by manipulating lymphohematopoietic stem-progenitor cells to express FasL or other immune-modulating genes in the context of BMT.<\/jats:p>","DOI":"10.1182\/blood-2002-01-0118","type":"journal-article","created":{"date-parts":[[2002,10,16]],"date-time":"2002-10-16T23:03:08Z","timestamp":1034809388000},"page":"3147-3154","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":28,"title":["Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation"],"prefix":"10.1182","volume":"100","author":[{"given":"Katharine A.","family":"Whartenby","sequence":"first","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Straley","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heeje","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Racke","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Tanavde","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin S.","family":"Gorski","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linzhao","family":"Cheng","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew M.","family":"Pardoll","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curt I.","family":"Civin","sequence":"additional","affiliation":[{"name":"From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111616474781000_B1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.193.2.233","article-title":"Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.","volume":"193","author":"Dhodapkar","year":"2001","journal-title":"J Exp Med."},{"key":"2019111616474781000_B2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8","article-title":"Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo.","volume":"30","author":"Lutz","year":"2000","journal-title":"Eur J Immunol."},{"key":"2019111616474781000_B3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jlb.66.2.293","article-title":"Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig).","volume":"66","author":"Lu","year":"1999","journal-title":"J Leukoc Biol."},{"key":"2019111616474781000_B4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/sj.gt.3300862","article-title":"Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients.","volume":"6","author":"Lu","year":"1999","journal-title":"Gene Ther."},{"key":"2019111616474781000_B5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/11375","article-title":"Induction of antigen-specific immunosuppression by CD95L cDNA-transfected \u201ckiller\u201d dendritic cells.","volume":"5","author":"Matsue","year":"1999","journal-title":"Nat Med."},{"key":"2019111616474781000_B6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.164.1.161","article-title":"Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival.","volume":"164","author":"Min","year":"2000","journal-title":"J Immunol."},{"key":"2019111616474781000_B7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4049\/jimmunol.159.3.1135","article-title":"ZAP-70 tyrosine kinase is required for the up-regulation of Fas ligand in activation-induced T cell apoptosis.","volume":"159","author":"Eischen","year":"1997","journal-title":"J Immunol."},{"key":"2019111616474781000_B8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nm0398-333","article-title":"An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow.","volume":"4","author":"George","year":"1998","journal-title":"Nat Med."},{"key":"2019111616474781000_B9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/373444a0","article-title":"Fas(CD95)\/FasL interactions required for programmed cell death after T-cell activation.","volume":"373","author":"Ju","year":"1995","journal-title":"Nature."},{"key":"2019111616474781000_B10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1126\/science.273.5271.109","article-title":"Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice.","volume":"273","author":"Lau","year":"1996","journal-title":"Science."},{"key":"2019111616474781000_B11","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1073\/pnas.94.8.3943","article-title":"Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.","volume":"94","author":"Allison","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2019111616474781000_B12","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4049\/jimmunol.167.3.1338","article-title":"Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts.","volume":"167","author":"Tourneur","year":"2001","journal-title":"J Immunol."},{"key":"2019111616474781000_B13","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1111\/j.1432-2277.2000.tb02051.x","article-title":"Fas ligand gene transfer combined with low dose cyclosporine A reduces acute lung allograft rejection.","volume":"13(suppl 1)","author":"Schmid","year":"2000","journal-title":"Transpl Int."},{"key":"2019111616474781000_B14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm0897-843","article-title":"Inhibition of the alloantibody response by CD95 ligand.","volume":"3","author":"Arai","year":"1997","journal-title":"Nat Med."},{"key":"2019111616474781000_B15","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1126\/science.282.5394.1714","article-title":"Regulation of the proinflammatory effects of Fas ligand (CD95L).","volume":"282","author":"Chen","year":"1998","journal-title":"Science."},{"key":"2019111616474781000_B16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.","volume":"272","author":"Naldini","year":"1996","journal-title":"Science."},{"key":"2019111616474781000_B17","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1128\/JVI.72.12.9873-9880.1998","article-title":"Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.","volume":"72","author":"Zufferey","year":"1998","journal-title":"J Virol."},{"key":"2019111616474781000_B18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector.","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene."},{"key":"2019111616474781000_B19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/10430340050015464","article-title":"Antigen-specific induction of peripheral T cell tolerance in vivo by codelivery of DNA vectors encoding antigen and Fas ligand.","volume":"11","author":"Georgantas","year":"2000","journal-title":"Hum Gene Ther."},{"key":"2019111616474781000_B20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/335271a0","article-title":"Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice.","volume":"335","author":"Sha","year":"1988","journal-title":"Nature."},{"key":"2019111616474781000_B21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1172\/JCI118832","article-title":"Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease.","volume":"98","author":"Perreault","year":"1996","journal-title":"J Clin Invest."},{"key":"2019111616474781000_B22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0264-410X(00)00379-0","article-title":"Evaluation of a recombinant Listeria monocytogenes expressing an HIV protein that protects mice against viral challenge.","volume":"19","author":"Mata","year":"2001","journal-title":"Vaccine."},{"key":"2019111616474781000_B23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm0196-80","article-title":"Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice.","volume":"2","author":"Lacronique","year":"1996","journal-title":"Nat Med."},{"key":"2019111616474781000_B24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0041-1345(00)02009-1","article-title":"Role of Fas\/Fasl in Kupffer cell-dependent deletion of alloantigen activated T cells following liver transplantation.","volume":"33","author":"Sun","year":"2001","journal-title":"Transplant Proc."},{"key":"2019111616474781000_B25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1634\/stemcells.20-2-174","article-title":"Human CD34+ hematopoietic stem\/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis.","volume":"20","author":"Kim","year":"2002","journal-title":"Stem Cells."},{"key":"2019111616474781000_B26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-9440(10)65316-3","article-title":"Fas\/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion.","volume":"154","author":"Yoong","year":"1999","journal-title":"Am J Pathol."},{"key":"2019111616474781000_B27","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.190.11.1679","article-title":"FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis.","volume":"190","author":"Perlman","year":"1999","journal-title":"J Exp Med."},{"key":"2019111616474781000_B28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.187.1.123","article-title":"Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand.","volume":"187","author":"Suzuki","year":"1998","journal-title":"J Exp Med."},{"key":"2019111616474781000_B29","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95's deadly mission in the immune system.","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature."},{"key":"2019111616474781000_B30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1521-4141(200001)30:1<155::AID-IMMU155>3.0.CO;2-X","article-title":"Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.","volume":"30","author":"Wang","year":"2000","journal-title":"Eur J Immunol."},{"key":"2019111616474781000_B31","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.94.12.5986","article-title":"Fas-ligand: privilege and peril.","volume":"94","author":"Green","year":"1997","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/9\/3147\/1258771\/h82102003147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/100\/9\/3147\/1258771\/h82102003147.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T23:13:26Z","timestamp":1682378006000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/100\/9\/3147\/16440\/Transduction-of-donor-hematopoietic-stemprogenitor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11,1]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,11,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2002-01-0118","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11,1]]}}}